Anaemia and heart failure: Aetiology and treatment

Nephrology Dialysis Transplantation

Volumn 20, Issue SUPPL. 7, 2005, Pages

  Klutstein, Marc W ^a   Tzivoni, Dan ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Anaemia; Heart failure; Prognosis; Renal failure; Treatment

Indexed keywords

ERYTHROPOIETIN; FREE RADICAL; HEMOGLOBIN; IRON;

ANEMIA; ARTICLE; BLOOD EXAMINATION; BONE MARROW DEPRESSION; DISEASE SEVERITY; HEART FAILURE; HEART OUTPUT; HEMODILUTION; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INFECTION RISK; IRON DEFICIENCY; KIDNEY FAILURE; NONHUMAN; OXIDATIVE STRESS; OXYGEN SUPPLY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE;

ANEMIA; ERYTHROPOIETIN; HEART FAILURE; HUMANS; IRON; KIDNEY FAILURE; PROGNOSIS;

EID: 27144517991     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh1100     Document Type: Article

References (30)

1. Mathew ST, Gottdiener JS. Kitzman D, Aurigemma G. Congestive heart failure in the elderly: The Cardiovascular Health Study. Am J Geriatr Cardiol 2004; 13: 61-68
2. Gitt AK, Wasserman K, Kilkowski C et al. Exercise anaerobic threshold and ventriculatory efficiency identify heart failure patients for high risk of early death. Circulation 2002; 106: 3079-3084
3. LeMaitre JP, Harris S, Fox KA, Denvir M. Change in circulating cytokines after 2 forms of exercise training in chronic stable heart failure. Am Heart J 2004; 147: 100-106
4. Hartmann F, Packer M, Coasts AJ et al. NT-proFNP in severe chronic heart failure: Rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Failure 2004; 6: 343-350
5. Richards AM, Nicholls MG, Espiner EA et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107: 2786-2792
6. Latini R, Masson S, Anand I et al. For the Val-HeFT investigators. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Vall-HeFT. Eur Heart J 2004; 25: 292-299
7. Braunwald E. Heart Disease, A Textbook of Cardiovascular Disease, 5th edn. Saunders Co. Philadelphia 1997: 1786-1787
8. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1780-1786
9. Okonko DO, Anker SD. Anemia in chronic heart failure. J Cardiac Fail 2004; 10: S5-S9
10. Witte KK, Clark AL. Nutritional abnormalities contributing to cachexia in chronic illness. Int J Cardiol 2002; 85: 23-31
11. Mustafa I, Leverve X. Metabolic and nutritional disorders in cardiac cachexia. Nutrition 2001; 17: 756-760
12. Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clarck AL. Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J 2004; 147: 924-930
13. Smoller BR, Kruskall MS. Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements. N Engl J Med 1986; 314: 1233-1235
14. Zeidman A, Fradin Z, Oster HS, Avrahami Y, Mittelman M. Anemia is a risk factor for ischemic heart disease. Isr Med Assoc J 2004; 6: 16-18
15. Iversen PO, Woldbaek PR, Tonnessen T, Christensen G. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol 2002; 282: R166-R172
16. Cleland JG, Swedberg K, Follath F et al. The Euro Heart Failure survey program - a survey on the quality of care among patients with heart failure in Europe. Part 1; patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-463
17. Felkler GM, Gattis WA, Leimberger JD et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 2003; 92: 625-628
18. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Insight from a cohort of 12065 patients with new-onset heart failure. Circulation 2003; 107: 223-225
19. Silverberg DS, Wexler D, Blum M, Iaina A. The cardiorenal anemia syndrome correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalization. Clin Nephrol 2003; 60 [Suppl 1]: S93-S102
20. Silverberg DS, Wexler D, Blum M et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35: 1737-1744
21. Silverberg DS, Wexler D, Sheps D et al. The effect of correction of mild anemia in severe resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol 2001; 37: 1775-1780
22. Silverberg DS, Wexler D, Blum M et al. The effect of correction of anemia in diabetics and non diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 2003; 18: 141-146
23. Conlon PJ, Kovalik E, Schumm D, Minda S, Schwab SJ. Normalization of hematocrit in hemodialysis patients does not affect silent ischemia. Renal Fail 2000; 22: 205-211
24. Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590
25. Fantana HI, Santanna J, Guo W et al. Iron administration and clinical outcomes in hemodialysis patients. J Am Soc Nephrol 2002; 13: 734-744
26. Collins A, Ebben J, Ma H, Xia J. I.V. iron dosing patterns and mortality. J Am Soc Nephrol 1998; 9: 205A [abstract]
27. Kurishev YA, Brittenham GM, Fujioka H et al. Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Implications for the arrhythmogenesis of human siderotic heart disease. Circulation 1999; 100: 675-683
28. Schwartz KA, Li Z, Schwartz DE, Cooper TG, Braselton WE. Earliest cardiac toxicity induced by iron overload selectively inhibits electrical conduction. J Appl Physiol 2002; 93: 746-751
29. Yang T, Dong WQ, Kuryshev YA et al. Bimodal cardiac dysfunction in an animal model of iron overload. J Lab Clin Med 2002; 140: 263-271
30. Topuzovic N. Worsening of left ventricular diastolic function during long term correction of anemia with erythropoietin in chronic hemodialysis patients; assessment by radionuclide ventriculography and exercise. Int J Cardiac Imaging 1999; 15: 233-239